Hemophilia, a genetic bleeding disorder, is often diagnosed late due to persistent myths and subtle early symptoms. Firstpost ...

Researchers explored the effects of opioid-sparing multimodal anesthesia embedded within an ERAS protocol on postoperative recovery in gynecologic oncologic surgery.

Dr Jane Ruth Aceng says Uganda is committed to ending AIDS as a public health threat by 2030 through a combination prevention ...

The Zacks Consensus Estimate for fiscal 2026 revenues indicates an improvement of 16.5% from the year-ago reported figure, while the same for earnings implies a rise of 25.2%. CAH carries a Zacks Rank ...

Discover essential insights about haemophilia, its impacts, symptoms, treatments, and the global push for better care and ...

Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument (also known as VEL-101), a novel investigational ...

The Zacks Medical - Dental Supplies industry in the Medical sector is likely to continue its upward momentum in 2026, backed ...

Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects for the development of drugs for malaria and neglected tropical diseases ...

A pain-informed model identified risk factors for clinically significant nausea in patients undergoing metabolic bariatric surgery.

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D ...

Dr. Peter Ogundeji, a Consultant Haematologist and Coordinator of the Haemophilia Treatment Centre at University College Hospital Ibadan, in this interview with Sade Oguntola highlights low ...

Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.